Christopher James | executive |
Joseph Ciaffoni | executive |
Colleen Tupper | executive |
Scott Dreyer | executive |
David Amsellem | analyst |
Lachlan Hanbury-Brown | analyst |
Serge Belanger | analyst |
Leszek Sulewski | analyst |
Greetings, and welcome to the Collegium Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded.
I will now turn the call over to Christopher James, Vice President of Investor Relations at Collegium. Thank you.
You may begin.